Ribociclib plus endocrine therapy improves survival in premenopausal patients with metastatic breast cancer

12:40 EDT 11 Jun 2019 | ecancermedicalscience

Prof Debu Tripathy speaks to ecancer at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting about the results from the MONALEESA-7 trial, which examined the combination of ribociclib and endocrine therapy in premenopausal patients with...

More From BioPortfolio on "Ribociclib plus endocrine therapy improves survival in premenopausal patients with metastatic breast cancer"